About Us
The Collaboration for Thrombosis and Bleeding disorders Research (CTBR) is an innovative research partnership committed to providing leadership and world class research to improve health outcomes for Australians suffering from thrombosis and bleeding disorders.
Venous thromboembolism (VTE) which includes deep vein thrombosis (DVT) and pulmonary embolism (PE) occurs in about 15000 people a year in Australia and it is thought that as many as 10% of deaths in Australian hospitals are the result of VTE. This is more than deaths from motor vehicle accidents, HIV AIDs and breast cancer put together. Many of these deaths could and should be prevented!
Hospital audits and clinical studies show that VTE prevention is grossly underused even in high risk patients in Australia. There is an urgent need for studies to identify reasons for inadequate VTE prophylaxis in hospitals and to identify effective measures to change doctor prescribing habits.
In addition, as treatment of VTE is being shifted in a cost cutting exercise, from the hospitals to General Practitioners, there is a need to carry out an evaluation of VTE management in the community.
Also, with a glut of new compounds for VTE treatment and prevention about to hit the Australian market, there is a need for population studies to monitor the adverse events of these drugs, in particular events that might have escaped detection in small, highly controlled pre-registration studies.
Research planned includes clinical, translational and population/community research on prevention and treatment to improve outcomes in patients with VTE and, with this in mind, the Collaboration for Thrombosis and Bleeding Disorders Research was conceived.
Mission
The Collaboration for Thrombosis and Bleeding Disorders Research has been established to improve Australian patient care by
- Conducting cutting edge, well designed research into thrombosis and bleeding disorders including its treatment and the medical management of patients with these conditions
- Disseminating knowledge to patients, clinicians, students and other health care professionals as well as government and the broader community about this specialty.
CTBR is a collaboration between research teams resulting in expertise in basic science, drug development, clinical research, community health, population health and health service research as well as thrombosis and bleeding disorders research and education, thus ensuring research excellence in clinical and translational research.
History
Milestones and Achievements
| Nov 2005 | National Institute of Clinical Studies identified VTE as an important health issue in Australia stating that '‘VTE prevention is a stand-out opportunity to improve patient safety” (National Institute of Clinical Studies (NICS) Venous Thromboembolism (VTE) prevention program – Project Definition Document – December 2005) |
| 2006 | CTBR was awarded a research grant by the University of New South Wales to assist with establishing the Unit |
| 2007 | CTBR received funding from industry for a research fellow
CTBR received funding from industry for a study coordinator |
| 2008 | The 4th edition of the ANZ VTE Prophylaxis Guidelines is launched |
| 2008 | An Australian VTE summit is convened to brainstorm ideas to improve VTE prophylaxis improvement in our hospitals |
Annual Reports